Repurposing of the ALK inhibitor crizotinib for acute leukemia and multiple myeloma cells - Boulos, Joelle; Saeed, Mohamed; Chatterjee, Manik; Bülbül, Yagmur; Crudo, Francesco; Marko, Doris; Munder, Markus; Klauck, Sabine; Efferth, Thomas (Pharmaceuticals, 2021)
Gesehen am 20.01.2022